Literature DB >> 16567886

Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time.

Uday C Ghoshal1, Ujjala Ghoshal, Kshaunish Das, Asha Misra.   

Abstract

BACKGROUND: Small intestinal bacterial overgrowth (SIBO), which may result from intestinal stasis, is common in malabsorption syndrome (MAS). Quantitative culture of upper gut aspirate is used as a gold standard for the diagnosis of SIBO. Studies on diagnosis of SIBO using non-invasive hydrogen breath tests are contradictory.
METHODS: 83 patients (age 35 [14-70] y; 50 men) with MAS due to various causes were investigated for SIBO using quantitative culture of upper gut aspirate obtained using a special endoscopic catheter and glucose and lactulose hydrogen breath tests (GHBT, LHBT). Sustained elevation in breath hydrogen of 12 ppm above basal and two separate peaks (one due to SIBO and the other from colon) were diagnostic of SIBO in GHBT and LHBT, respectively. Oro-cecal transit time (OCTT) was estimated using LHBT in 71 patients.
RESULTS: Thirty two of 81 (39.5%) patients with MAS had SIBO on culture (>or= 10(5) CFU/mL). Using aspirate culture as the gold standard, sensitivity, specificity, positive and negative predictive values and diagnostic accuracy of GHBT to diagnose SIBO were 44%, 80%, 62%, 67% and 65%, respectively; the corresponding values for LHBT were 31%, 86%, 62%, 54% and 55%, respectively. OCTT in patients with SIBO diagnosed on GHBT and/or aspirate culture (n=58) was longer than in those without (170 [60-250] vs. 120 [50-290] min, p=0.02); of others, 7 were hydrogen non-producers and in 6 OCTT could not be assessed due to sustained early peak because of SIBO.
CONCLUSIONS: GHBT and LHBT are highly specific but insensitive for diagnosis of SIBO in MAS; OCTT is longer in patients with MAS and SIBO than in those without.

Entities:  

Mesh:

Year:  2006        PMID: 16567886

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  44 in total

Review 1.  A systematic review of diagnostic tests for small intestinal bacterial overgrowth.

Authors:  Reza Khoshini; Sun-Chuan Dai; Sheila Lezcano; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

2.  Stunted childhood growth is associated with decompartmentalization of the gastrointestinal tract and overgrowth of oropharyngeal taxa.

Authors:  Pascale Vonaesch; Evan Morien; Lova Andrianonimiadana; Hugues Sanke; Jean-Robert Mbecko; Kelsey E Huus; Tanteliniaina Naharimanananirina; Bolmbaye Privat Gondje; Synthia Nazita Nigatoloum; Sonia Sandrine Vondo; Jepthé Estimé Kaleb Kandou; Rindra Randremanana; Maheninasy Rakotondrainipiana; Florent Mazel; Serge Ghislain Djorie; Jean-Chrysostome Gody; B Brett Finlay; Pierre-Alain Rubbo; Laura Wegener Parfrey; Jean-Marc Collard; Philippe J Sansonetti
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

3.  The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin.

Authors:  Manuele Furnari; Alessandra De Alessandri; Federico Cresta; Maria Haupt; Marta Bassi; Angela Calvi; Riccardo Haupt; Giorgia Bodini; Iftikhar Ahmed; Francesca Bagnasco; Edoardo Giovanni Giannini; Rosaria Casciaro
Journal:  J Gastroenterol       Date:  2018-09-19       Impact factor: 7.527

Review 4.  Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome.

Authors:  Pejman Katiraei; Gilberto Bultron
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

5.  SIBO in gastroparesis: sci-fi or science fact?

Authors:  John O Clarke
Journal:  Dig Dis Sci       Date:  2014-01-17       Impact factor: 3.199

6.  Small intestinal bacterial overgrowth in gastroparesis.

Authors:  Nina S George; Abhinav Sankineni; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2012-10-05       Impact factor: 3.199

7.  Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state.

Authors:  Sunil Kumar; Asha Misra; Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

8.  Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea.

Authors:  Uday C Ghoshal; Sunil Kumar; Mansi Mehrotra; Cp Lakshmi; Asha Misra
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

9.  Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease.

Authors:  Andre Fialho; Andrea Fialho; Gursimran Kochhar; Aldo L Schenone; Prashanti Thota; Arthur J McCullough; Bo Shen
Journal:  Dig Dis Sci       Date:  2017-11-06       Impact factor: 3.199

10.  Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Authors:  Sergio Peralta; Claudia Cottone; Tiziana Doveri; Piero Luigi Almasio; Antonio Craxi
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.